Bridgeway Capital Management’s Hardinge Inc HDNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-234,600
Closed -$4.3M 1489
2018
Q1
$4.3M Sell
234,600
-200
-0.1% -$3.65K 0.05% 335
2017
Q4
$4.09M Buy
234,800
+200
+0.1% +$3.31K 0.04% 348
2017
Q3
$3.58M Hold
234,600
0.04% 377
2017
Q2
$2.91M Sell
234,600
-30,600
-12% -$353K 0.04% 430
2017
Q1
$2.98M Buy
265,200
+30,600
+13% +$332K 0.04% 420
2016
Q4
$2.6M Hold
234,600
0.03% 474
2016
Q3
$2.61M Hold
234,600
0.04% 423
2016
Q2
$2.36M Hold
234,600
0.04% 452
2016
Q1
$2.92M Hold
234,600
0.05% 372
2015
Q4
$2.19M Buy
234,600
+22,800
+11% +$215K 0.04% 471
2015
Q3
$1.94M Hold
211,800
0.04% 497
2015
Q2
$2.09M Hold
211,800
0.04% 498
2015
Q1
$2.46M Buy
211,800
+124,200
+142% +$1.42M 0.05% 455
2014
Q4
$1.04M Hold
87,600
0.02% 752
2014
Q3
$958K Hold
87,600
0.02% 772
2014
Q2
$1.11M Hold
87,600
0.03% 733
2014
Q1
$1.26M Hold
87,600
0.04% 662
2013
Q4
$1.27M Hold
87,600
0.04% 660
2013
Q3
$1.35M Hold
87,600
0.05% 590
2013
Q2
$1.29M Buy
+87,600
New +$1.18M 0.05% 521

Bridgeway Capital Management's HDNG Position: Q2 2018 in Review

Bridgeway Capital Management sold out of Hardinge Inc (HDNG) in Q2 2018, closing a stake of 234,600 shares — an estimated $4.3M sold.

Bridgeway Capital Management first reported a position in HDNG in Q2 2013 and held it in 20 quarters. The position peaked at $4.3M in Q1 2018. 0 funds tracked by Wall St. Rank hold HDNG as of Q2 2018.

  • Bridgeway Capital Management reported no remaining Hardinge Inc position as of Q2 2018 after selling out during the quarter.
  • Bridgeway Capital Management sold 234,600 Hardinge Inc shares in Q2 2018, an estimated $4.3M.
  • Bridgeway Capital Management first reported a position in Hardinge Inc in Q2 2013 and held it in 20 quarters.
  • Bridgeway Capital Management's Hardinge Inc position peaked at $4.3M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Hardinge Inc as of Q2 2018.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.